Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer

Table 1

Clinicopathological characteristics according to neutrophil/lymphocyte ratio.

Variable	n (%) ()	Neutrophil/lymphocyte ratio		value
		≤1.8 ()	>1.8 ()
Age				0.011
<50 years	162 (35.1)	98 (40.5)	64 (29.1)
≥50 years	300 (64.9)	144 (59.5)	156 (70.9)
Stage				0.195
IA2	42 (9.1)	26 (10.7)	16 (7.3)
IB1	420 (90.9)	216 (89.3)	204 (92.7)
Histology				0.424
Squamous carcinoma	270 (58.5)	134 (55.4)	136 (61.8)
Adenocarcinoma	153 (33.1)	86 (35.5)	67 (30.5)
Adenosquamous carcinoma	26 (5.6)	16 (6.6)	10 (4.5)
Others	13 (2.8)	6 (2.5)	7 (3.2)
Tumor size				0.045
≤2 cm	311 (67.3)	173 (71.5)	138 (62.7)
>2 cm	151 (32.7)	69 (28.5)	82 (37.3)
Lymph vascular space invasion				0.630
No	347 (75.1)	184 (76.0)	163 (74.1)
Yes	115 (24.9)	58 (24.0)	57 (25.9)
Deep stromal invasion				0.353
No	341 (73.8)	183 (75.6)	158 (71.8)
Yes	121 (26.2)	59 (24.4)	62 (28.2)
Parametrial involvement				0.982
No	443 (95.9)	232 (95.9)	211 (95.9)
Yes	19 (4.1)	10 (4.1)	9 (4.1)
Lymph node status				0.280
No	438 (94.8)	232 (95.8)	206 (93.6)
Yes	24 (5.2)	10 (4.1)	14 (6.4)
Vaginal margin				0.837
No	444 (96.1)	233 (96.3)	211 (95.9)
Yes	18 (3.9)	9 (3.7)	9 (4.1)
Adjuvant treatment				0.005
No	368 (79.7)	205 (84.7)	163 (74.1)
Yes	94 (20.3)	37 (15.3)	57 (25.9)